(19)
(11) EP 1 844 052 A1

(12)

(43) Date of publication:
17.10.2007 Bulletin 2007/42

(21) Application number: 06710294.7

(22) Date of filing: 17.01.2006
(51) International Patent Classification (IPC): 
C07D 495/04(2006.01)
A61K 31/519(2006.01)
A61P 7/02(2006.01)
(86) International application number:
PCT/IB2006/000172
(87) International publication number:
WO 2006/079916 (03.08.2006 Gazette 2006/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 26.01.2005 US 647340 P
07.03.2005 US 659337 P

(71) Applicant: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001-0199 (US)

(72) Inventors:
  • ENNIS, Michael Dalton, Pfizer Global R & D
    Chesterfield, MO 63017-1732 (US)
  • KORTUM, Steven Wade, Pfizer Global R & D
    Chesterfield, MO 63017-1732 (US)
  • RAHMAN, Hayat, Pfizer Global R & D
    Chesterfield, MO 63017-1732 (US)
  • SCHWEITZER, Barbara Ann, Pfizer Global R & D
    Chesterfield, MO 63017-1732 (US)
  • TENBRINK, Ruth Elizabeth, Pfizer Global R & D
    Chesterfield, MO 63017-1732 (US)

(74) Representative: Rudge, Andrew John 
Pfizer Limited European Patent Department
Ramsgate Road Sandwich CT13 9NJ
Ramsgate Road Sandwich CT13 9NJ (GB)

   


(54) THIENO[2,3-D]PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION